“Our team is deeply honoured to receive the prestigious 2025 Display Component of the Year Award for FlexEnable’s high-performance FlexiOM OTFT materials,” said Chuck Milligan, CEO of FlexEnable.

  • Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event
  • Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”
  • Event supported by VisitBritain showcases UK life science sector and extends interna
  • Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive Director
  • Strategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platform

San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, announces it has raised $8 million USD Seed investment.

Creightons, up 18.3%, announced that it has promoted Mohammed Qadeer (known as Qadeer), the company's Chief Financial Officer (CFO), to the Board of Directors, effective 1 May 2025. 

His insights are highly relevant for the UK life sciences sector, particularly as it navigates the challenges of a shrinking domestic manufacturing base.

Looking for something specific?

“Our team is deeply honoured to receive the prestigious 2025 Display Component of the Year Award for FlexEnable’s high-performance FlexiOM OTFT materials,” said Chuck Milligan, CEO of FlexEnable.

  • Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event
  • Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”
  • Event supported by VisitBritain showcases UK life science sector and extends interna
  • Barbara Duncan joins as Chair and Stephen Dilly as Non-Executive Director
  • Strategic appointments support progression of PhoreMost’s next generation degrader pipeline through preclinical development and commercialisation of its GlueSEEKER® platform

San Francisco, US, 06 May 2025: Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, announces it has raised $8 million USD Seed investment.

Creightons, up 18.3%, announced that it has promoted Mohammed Qadeer (known as Qadeer), the company's Chief Financial Officer (CFO), to the Board of Directors, effective 1 May 2025. 

His insights are highly relevant for the UK life sciences sector, particularly as it navigates the challenges of a shrinking domestic manufacturing base.